Quality of Life in MS Patients with Gait Disorders
A study planned to enroll 28 participants with multiple sclerosis (MS) to evaluate the use of a robotic exoskeleton as a walking aid. This multicenter, controlled, randomized trial intends to measure its effects on quality of life over a 3-month follow-up period, but no results are currently posted.
- Tags
- #Other
- Most relevant to
- —
- Source
- Read original source
Why it matters
Understanding whether a robotic exoskeleton can improve the quality of life for MS patients could inform future interventions for gait disorders, a common issue in this population.
What this does not prove
No results are posted; thus, outcomes and endpoints are not available. The planned enrollment and study design are not findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- Not reported
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Other
Original sources
Supporting passages (9)
study designIt is a multicenter, controlled, randomized, cross-over, open-label clinical investigation.
subjectsPatients with multiple sclerosis with an Expanded Disability Status Scale (EDSS) between 5 and 6.5,living at home and using an assistive device for walking will be included.
randomizedAfter enrollment, patients will be randomised in one of the 2 study-arm.
controlledIt is a multicenter, controlled, randomized, cross-over, open-label clinical investigation.
research categoriesquality of life in patients with multiple sclerosis with gait disorders.
relevant ms typesThe goal of this clinical investigation is to evaluate the effectiveness of home use of a lightweight robotic lower limb exoskeleton as a walking aid device on quality of life in patients with multiple sclerosis with gait disorders.
follow up3 months of follow-up.
findingsNo results are posted.
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.